Delivery Order SPE2DR25D1110-SPE2DR26F13RX
- Not listed
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $5,686.24 on January 27, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. The Defense Logistics Agency (DLA) issued this firm fixed-price, non-set-aside contract, with performance to be completed by January 28, 2026, at the contractor's location in Conshohocken, Pennsylvania. This delivery order represents a task order execution under Cencora's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $35,243.16 to Amerisourcebergen Drug Corp (parent company Cencora, Inc.) on January 16, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 20, 2026, and performance to be fulfilled from the contractor's Conshohocken, Pennsylvania location. The delivery order is issued under Amerisourcebergen's existing Indefinite...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $7,258.92 by the Defense Logistics Agency (DLA) on January 13, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded transaction. Performance will be completed at the awardee's location in Conshohocken, Pennsylvania, with an ultimate completion date of January 14,...
- The Defense Logistics Agency awarded a $16,550.52 delivery order to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on January 8, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed-price contract is scheduled for completion by January 9, 2026, and will be performed at AmerisourceBergen's headquarters in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation, indicating the award was made through full...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $5,857.21 by the Defense Logistics Agency (DLA) on December 11, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 12, 2025, and represents performance at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a firm fixed-price delivery order valued at $33,760.01 by the Defense Logistics Agency on January 27, 2026, for the supply of Repatha 140 mg/mL SureClick auto-injector medication. The delivery order, which carries an ultimate completion date of January 28, 2026, represents a non-competitive award issued without set-aside designation. Performance will be executed from the awardee's corporate office location in Conshohocken,...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $44,909.34 by the Defense Logistics Agency on January 28, 2026, for the supply of Repatha 140 mg/mL SureClick auto-injectors. The contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open competition. Performance will be executed from the prime contractor's location in Conshohocken, Pennsylvania, with an ultimate completion date...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $13,073.19 by the Defense Logistics Agency (DLA) on December 4, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This firm fixed price, non-competitive delivery order represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and running through December 2026. The contractor, headquartered in...
- The Defense Logistics Agency awarded a $30,283.68 delivery order to AmerSourceBergen Drug Corp (a subsidiary of parent company Cencora, Inc.) on January 22, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with an ultimate completion date of January 23, 2026. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a task...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $61,117.01 by the Defense Logistics Agency on January 12, 2026, for the supply of Repatha 140 mg/mL SureClick auto-injectors. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The ultimate completion date is set for January 13, 2026. This delivery order is executed under...
- SPE2DR25D1110Indefinite Delivery Contract
- SPE2DR25D1110-SPE2DR26F13RXDelivery Order
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a $6,497.25 delivery order by the Defense Logistics Agency on January 21, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract is non-competitive and structured as a firm fixed-price delivery order with an ultimate completion date of January 22, 2026. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is executed under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of medications and medical supplies to military healthcare programs worldwide. Repatha (evolocumab) is a specialty pharmaceutical product used in cardiovascular disease management for cholesterol reduction in high-risk patients. The award reflects the Defense Logistics Agency's ongoing procurement of critical pharmaceutical commodities to support military treatment facilities and veteran healthcare programs. Amerisourcebergen's role as a primary pharmaceutical distributor to federal agencies, combined with its established capability to deliver specialty medications efficiently, positions the company as a key supplier for the Department of Defense medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.5k | 1/20/26 |